OConnell Daniel Joseph
Chief Executive Officer at ABOS
- Sold, on record
- $324k
- Dollars the filings state
- Form 4 sales
- 6
- Latest Jan 22, 2026
- Form 144 notices
- 1
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- ABOSAcumen Pharmaceuticals, Inc.Chief Executive Officer
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale ABOSRoutineJan 19 2024
Sold 15,200 shares at $3.47 ($53k)
OConnell Daniel Joseph, President and CEO
10b5-1 planSold 2.9% of holdings ($1.8M position)502,485 shares leftFirst sale on recordFollows a Form 144Filing
- 2 Form 144 notice ABOSNoticeJan 19 same day
Filed to sell 15,200 shares ($53k)
OConnell Daniel Joseph, Officer, Director
10b5-1 planFirst sale on recordFiling
- 3 Form 4 sale ABOSRoutineJan 3 +350 days
Sold 47,778 shares at $1.84 ($88k)
OConnell Daniel Joseph, Chief Executive Officer
10b5-1 planSold 9.5% of holdings ($925k position)454,707 shares leftFiling
- 4 Form 4 sale ABOSRoutineJan 21 +18 days
Sold 12,619 shares at $1.59 ($20k)
OConnell Daniel Joseph, Chief Executive Officer
10b5-1 planSold 1.9% of holdings ($1.1M position)667,488 shares leftFiling
- 5 Form 4 sale ABOSUnusualJan 7 +351 days
Sold 47,506 shares at $1.99 ($94k)
OConnell Daniel Joseph, Chief Executive Officer
No 10b5-1 planSold 7.1% of holdings ($1.3M position)619,982 shares left3.1x usual sizeFiling
- 6 Form 4 sale ABOSNo planJan 12 +5 days
Sold 26,472 shares at $1.77 ($47k)
OConnell Daniel Joseph, Chief Executive Officer
No 10b5-1 planSold 4.3% of holdings ($1.1M position)593,510 shares left0.8x usual sizeFiling
- 7 Form 4 sale ABOSNo planJan 22 +10 days
Sold 12,035 shares at $1.83 ($22k)
OConnell Daniel Joseph, Chief Executive Officer
No 10b5-1 planSold 1.3% of holdings ($1.6M position)881,275 shares left0.3x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (7)
| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| Jan 22, 2026 | ABOS | Chief Executive Officer | Form 4 sale | 12,035 | $22k | 1.3% | No plan | SEC |
| Jan 12, 2026 | ABOS | Chief Executive Officer | Form 4 sale | 26,472 | $47k | 4.3% | No plan | SEC |
| Jan 7, 2026 | ABOS | Chief Executive Officer | Form 4 sale | 47,506 | $94k | 7.1% | Unusual | SEC |
| Jan 21, 2025 | ABOS | Chief Executive Officer | Form 4 sale | 12,619 | $20k | 1.9% | Routine | SEC |
| Jan 3, 2025 | ABOS | Chief Executive Officer | Form 4 sale | 47,778 | $88k | 9.5% | Routine | SEC |
| Jan 19, 2024 | ABOS | Officer, Director | Form 144 notice | 15,200 | $53k | Notice | SEC | |
| Jan 19, 2024 | ABOS | President and CEO | Form 4 sale | 15,200 | $53k | 2.9% | Routine | SEC |